Skip to main content
    N

    Neurogene Inc (NGNE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $23.10
    -0.20 (-0.86%)

    Market Cap: $482.33M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Neurogene Inc (NGNE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Neurogene (NGNE) has a latest price of $23.10 on Nov 17, 2026, 47.1% below its 52-week high of $43.66. Its price rose 1.4% over the past 12 months. The month-end price fell 86.8% over the 10 years through Oct 2026, a compound annual decline of 18.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $361.20 in Jan 2017 and its lowest $10.07 in Feb 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NGNE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NGNE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 41.4%, and over 6 months it fell 14.1%. The month-end price rose 103.8% over the 3 years through Oct 2026, a compound annual rate of 26.8%.

    PeriodChange
    1 month-4.4%
    3 months-41.4%
    6 months-14.1%
    12 months+1.4%
    12 months, with dividends+1.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+103.8%+26.8%
    5 years-81.2%-28.4%
    10 years-86.8%-18.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 470.4%, and its weakest was 2022, when it fell 89.4%.

    YearCloseChange
    2026 through Oct 2026$27.55+33.7%
    2025$20.60-9.9%
    2024$22.86+18.0%
    2023$19.38+90.4%
    2022$10.18-89.4%
    2021$96.40-65.8%
    2020$282.00+14.4%
    2019$246.40+470.4%
    2018$43.20-81.6%
    2017$235.20-28.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 16.3% below its 50-day average of $27.61 and 18.1% below its 200-day average of $28.22.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$23.10
    52-week high$43.66-47.1%
    52-week low$15.93+45.0%
    50-day average$27.61-16.3%
    200-day average$28.22-18.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 89.7%.

    MeasureValue
    1-year beta1.44
    Largest fall, 1 year-49.7%
    Largest fall, 3 years-89.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NGNE

    What is NGNE's 1-year price change?

    Neurogene's price rose 1.4% over the past 12 months. With dividends included, the 12-month total return was 1.4%.

    What is NGNE's 5-year price change?

    Neurogene's month-end price fell 81.2% over the 5 years through Oct 2026, a compound annual decline of 28.4%. These figures leave out dividends.

    What is NGNE's 52-week high and low?

    Neurogene's 52-week high is $43.66 and its 52-week low is $15.93. Its latest price of $23.10 on Nov 17, 2026 is 47.1% below the high.

    What is NGNE's beta?

    Neurogene's 1-year beta against the S&P 500 is 1.44, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 49.7%.

    Is the NGNE chart free?

    Yes. Advanced Charting for NGNE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.